2qlq: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 10: | Line 10: | ||
{{STRUCTURE_2qlq| PDB=2qlq | SCENE= }} | {{STRUCTURE_2qlq| PDB=2qlq | SCENE= }} | ||
===Crystal structure of | ===Crystal structure of SRC kinase domain with covalent inhibitor RL3=== | ||
| Line 46: | Line 46: | ||
[[Category: Tyrosine-protein kinase]] | [[Category: Tyrosine-protein kinase]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Mar 4 14:11:54 2009'' | ||
Revision as of 15:11, 4 March 2009
Crystal structure of SRC kinase domain with covalent inhibitor RL3Crystal structure of SRC kinase domain with covalent inhibitor RL3
Template:ABSTRACT PUBMED 18316192
About this StructureAbout this Structure
2QLQ is a 2 chains structure of sequences from Gallus gallus. Full crystallographic information is available from OCA.
ReferenceReference
- ↑ Michalczyk A, Kluter S, Rode HB, Simard JR, Grutter C, Rabiller M, Rauh D. Structural insights into how irreversible inhibitors can overcome drug resistance in EGFR. Bioorg Med Chem. 2008 Apr 1;16(7):3482-8. Epub 2008 Feb 20. PMID:18316192 doi:10.1016/j.bmc.2008.02.053
Page seeded by OCA on Wed Mar 4 14:11:54 2009
Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)
OCACategories:
- Pages with broken file links
- Gallus gallus
- Non-specific protein-tyrosine kinase
- Gruetter, C.
- Michalczyk, A.
- Rauh, D.
- Rode, H B.
- Alternative splicing
- Atp-binding
- Drug resistance
- Irreversible inhibitor
- Kovalent inhibitor
- Lipoprotein
- Myristate
- Nucleotide-binding
- Phosphorylation
- Proto-oncogene
- Sh2 domain
- Sh3 domain
- Src kinase domain
- Transferase
- Tyrosine-protein kinase